QR Kod

Humoral and cellular immunogenicity two months after SARS-CoV-2 messenger RNA vaccines in patients with cancer

Summary: Little is known on the long-lasting humoral response and the T cell activation induced by SARS-CoV-2 mRNA vaccines in patients with cancer. The study assessed the efficacy of the SARS-CoV-2 mRNA vaccines through measuring the seroconversion rate at pre-specified time points and the effect o...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: Natacha Bordry, Alfredo Addeo, Cyril Jaksic, Valérie Dutoit, Pascale Roux-Lombard, Dimpy P. Shah, Pankil K. Shah, Angèle Gayet-Ageron, Alex Friedlaender, Sébastien Bugeia, Garance Gutknecht, Anna Battagin, Maragrazia Di Marco, Pierre-Francois Simand, Intidhar Ladibi-Galy, Sarah Fertani, José Sandoval, Pierre-Yves Dietrich, Nicolas Mach
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2022-01-01
Seri Bilgileri:iScience
Konular:
Biological sciences
Immune response
Virology
Online Erişim:http://www.sciencedirect.com/science/article/pii/S2589004221016692
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller